Pipeline Watch

  • Pipeline Watch: 13 Approvals And Two Phase III Readouts

     
    • By 

    Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.

  • Pipeline Watch: 23 Approvals And Three Phase III Readouts

     
    • By 

    Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.

  • Pipeline Watch: 11 Approvals And Seven Phase III Readouts

     
    • By 

    Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.

  • Pipeline Watch: 16 Approvals And 16 Phase III Readouts

     
    • By 

    Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.

  • Pipeline Watch: Eight Approvals and Eight Phase III Updates

     
    • By 

    Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.

  • Pipeline Watch: 10 Phase III Updates Plus Voquezna And Other Approvals

     
    • By 

    Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.

  • Pipeline Watch: 11 Approvals And Two Phase III Readouts

     
    • By 

    Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.

  • Pipeline Watch: Nine Approvals And Five Phase III Readouts

     
    • By 

    Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.

  • Pipeline Watch: 23 Approvals And 14 Phase III Readouts

     
    • By 

    Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.

  • Pipeline Watch: 12 Approvals And 18 Phase III Readouts

     
    • By 

    Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.

  • Pipeline Watch: 8 Approvals and 15 Phase III Updates

     
    • By 

    Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.

  • Pipeline Watch: Respiratory Syncytial Virus Vaccine approved in the US As ASCO Dominates Clinical Trial Readouts

     
    • By 

    Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.

  • Pipeline Watch: 10 Approvals And 23 Phase III Readouts

     
    • By 

    Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.

  • Pipeline Watch: Five Approvals And 19 Phase III Read-Outs

     
    • By 

    Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.

  • Pipeline Watch: Six Approvals And 12 Phase III Readouts

     
    • By 

    Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.

  • Pipeline Watch: Five Approvals And 13 Phase III Readouts

     
    • By 

    Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.

  • Pipeline Watch: Six Approvals And 13 Phase III Updates

     
    • By 

    Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.

  • Pipeline Watch: Eighteen Approvals And Six Phase III Trial Updates

     
    • By 

    Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.

  • Pipeline Watch: Five Approvals And 23 Phase III Updates

     
    • By 

    Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.

  • Pipeline Watch: Six Approvals And 15 Phase III Updates

     
    • By 

    Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.    

ADVERTISEMENT